Cargando…
Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors
As described in the previous chapter, most kinase inhibitors that have been developed for use in the clinic act by blocking ATP binding; however, there is growing interest in identifying compounds that target kinase activities and functions without interfering with the conserved features of the ATP-...
Autores principales: | Martinez, Ramon, Defnet, Amy, Shapiro, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359047/ http://dx.doi.org/10.1007/978-3-030-48283-1_3 |
Ejemplares similares
-
Proteomic Changes in the Monolayer and Spheroid Melanoma
Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors
por: Martinez, Ramon, et al.
Publicado: (2022) -
Ortsaufgeloeste Photoluminiszensmessungen an III-IV und II-VI Halbleitermaterialien
por: Gloeckler, T
Publicado: (2001) -
Co-opting ATP-generating glycolytic enzyme PGK1 phosphoglycerate kinase facilitates the assembly of viral replicase complexes
por: Prasanth, K. Reddisiva, et al.
Publicado: (2017) -
60 Studi in II. III. IV. V. VI. VII. posizione
por: Curci, Alberto
Publicado: (1958) -
Consent in escrow: opting to opt in
por: Van der Loos, Kiah I., et al.
Publicado: (2015)